XML 69 R54.htm IDEA: XBRL DOCUMENT
v3.23.1

Investments - Additional Information, Accrued Performance Fees (Details) $ in Millions | 3 Months Ended | 12 Months Ended
--- | --- | ---
Mar. 31, 2023 USD ($) financingVehicle | Mar. 31, 2022 USD ($) | Dec. 31, 2022 fund
Concentration Risk [Line Items] |  |  |
Number of partnerships corporate private equity funds related to accrued performance fees | 2 |  | 1
Total | $ 160.8 | $ 710.2 |
Carlyle Partners VI, L.P. | Accrued performance allocations | Customer concentration risk |  |  |
Concentration Risk [Line Items] |  |  |
Percentage of accrued performance fees related to certain Corporate Private Equity funds (percent) | 22.00% |  | 13.00%

X
- Definition Number of partnerships corporate private equity funds related to accrued performance fees. + References No definition available. + Details
Name: | cg_NumberOfPartnershipsCorporatePrivateEquityFundsRelatedToAccruedPerformanceFees
Namespace Prefix: | cg_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Performance Allocation Investment Income (Loss) + References No definition available. + Details
Name: | cg_PerformanceAllocationInvestmentIncomeLoss
Namespace Prefix: | cg_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ConcentrationRiskLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 18 -URI https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -URI https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 20 -URI https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592 + Details
Name: | us-gaap_ConcentrationRiskPercentage1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_MajorCustomersAxis=cg_CarlylePartnersVIL.P.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByBenchmarkAxis=cg_AccruedPerformanceAllocationsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |